文献速递瓣膜病与结构性心脏病冠心病

经导管主动脉瓣置换术对重度主动脉瓣狭窄患者肾功能的影响

[Impact of transcatheter aortic valve replacement on renal function in patients with severe aortic stenosis].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2021-01-11

单中心回顾性研究纳入217例接受TAVR的重度主动脉瓣狭窄患者,按术前eGFR分组,分析术后72小时肾功能变化。结果显示39.2%患者出现急性肾功能恢复,仅1.4%发生急性肾损伤,BMI、术前LVEDD和术前eGFR与术后非急性肾功能恢复相关。

要点

  • TAVR术后大多数患者肾功能不变或改善,AKI发生率仅1.4%。
  • 术前eGFR越低,术后急性肾功能恢复比例越高。
  • BMI、术前LVEDD和术前eGFR是术后非AKR的危险因素。

核心结论

  • TAVR术后绝大多数患者表现为肾功能不变或改善。
  • TAVR术后肾功能变化与BMI及术前LVEDD、eGFR相关。

研究设计与样本

  • 单中心回顾性研究,连续入选2014年10月至2019年10月在复旦大学附属中山医院行TAVR治疗的主动脉瓣狭窄患者217例。
  • 依据术前1天eGFR分为4组:>90、>60~90、>30~60和≤30 ml·min-1·1.73m-2组。
  • 术后72小时按eGFR变化分为AKR组、AKI组和肾功能无变化组。

主要发现

  • >90、>60~90、>30~60和≤30 ml·min-1·1.73m-2组术后达AKR者所占比例分别为0、30.2%(35/116)、58.6%(41/70)和75.0%(9/12)。
  • 共3例(1.4%)患者发生AKI,其中>30~60组2例,>60~90组1例;eGFR<60 ml·min-1·1.73m-2患者中AKI发生率为2.4%(2/82)。
  • 217例中AKR组85例(39.2%)、AKI组3例(1.4%)、肾功能无变化组129例(59.4%)。
  • 3组的BMI、术前LVEDD和术前eGFR分布差异有统计学意义(P均<0.05)。
  • 多因素logistic回归显示BMI(OR=5.54,95%CI 1.04~29.58,P=0.045)、术前LVEDD(OR=1.22,95%CI 1.09~1.38,P=0.001)及术前eGFR(OR=2.23,95%CI 2.04~2.55,P=0.004)是术后非AKR的危险因素。

关键数值与推荐

  • AKR定义为TAVR术后72小时eGFR值增加>基线值的25%。
  • AKI定义为TAVR术后72小时eGFR值降低>基线值的25%。

临床怎么用

  • TAVR术前应关注BMI、LVEDD和eGFR,以评估术后肾功能变化风险。
  • 术前eGFR较低的患者术后肾功能恢复比例较高,但需警惕AKI发生。

局限性

  • 单中心回顾性研究,样本量有限,结论需多中心前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the impact of transcatheter aortic valve replacement (TAVR) on renal function in patients with severe aortic stenosis. Methods: This is a single-center retrospective study. Consecutive patients with severe aortic valve stenosis and received TAVR in Zhongshan Hospital from December 2014 to December 2019 were included. The patients were divided into four groups according to the estimate glomerular filtration rate (eGFR) measured at one day before TAVR, namely eGFR>90 ml·min-1·1.73m-2 group, 60<eGFR≤90 ml·min-1·1.73m-2 group, 30<eGFR≤60 ml·min-1·1.73m-2 group and eGFR≤30 ml·min-1·1.73m-2 group. The patients were also divided into acute renal function recovery (AKR) group, acute kidney injury (AKI) group and no change in renal function group according to renal function changes at 72 hours after TAVR. AKR was defined as eGFR increased by more than 25% of the baseline value at 72 hours after TAVR, and AKI was defined as eGFR decreased more than 25% of the baseline value at 72 hours after TAVR. The clinical data of each group were compared, and multivariate logistic regression analysis was performed to analyze the determinants responsible for renal function changes after TAVR. Results: A total of 217 patients were enrolled in this study. The age was (76.7±7.4) years and there were 86 females. The Society of Thoracic Surgeons score was (9.5±5.8). The proportions achieved AKR after TAVR were 0, 30.2% (35/116), 58.6% (41/70) and 75.0% (9/12) respectively in eGFR>90 ml·min-1·1.73m-2 group, 60<eGFR≤90 ml·min-1·1.73m-2 group, 30<eGFR≤60 ml·min-1·1.73m-2 group and eGFR≤30 ml·min-1·1.73m-2 group. A total of 3 patients (1.4%) suffered AKI, including 2 patients in 30<eGFR≤60 ml·min-1·1.73m-2 group and 1 patient in 60<eGFR≤90 ml·min-1·1.73m-2 group. The incidence of AKI in eGFR<60 ml·min-1·1.73m-2 group was 2.4% (2/82). Among the 217 patients, AKR occurred in 85(39.2%) patients, 3(1.4%) experienced AKI and renal function remained unchanged in 129 (59.4%) patients post TAVR. Body mass index (BMI), left ventricular end diastolic dimension (LVEDD) and preoperative eGFR were statistically different between the 3 groups (P<0.05). Multivariate logistic regression analysis showed that BMI (OR=5.54, 95%CI 1.04-29.58, P=0.045), preoperative LVEDD (OR=1.22, 95%CI 1.09-1.38, P=0.001) and preoperative eGFR (OR=2.23, 95%CI 2.04-2.55, P=0.004) were associated with non-AKR post TAVR. Conclusions: After TAVR, most patients show no change or improvement of renal function. BMI, preoperative LVEDD and eGFR are related to renal function change after TAVR. 目的: 探讨经导管主动脉瓣置换术(TAVR)对主动脉瓣狭窄患者术后肾功能的影响。 方法: 本研究为单中心回顾性研究。连续入选2014年10月至2019年10月在复旦大学附属中山医院行TAVR治疗的主动脉瓣狭窄患者。依据术前1 d肾小球滤过率(eGFR)将纳入患者分为4组:>90 ml·min-1·1.73m-2组、>60~90 ml·min-1·1.73m-2组、>30~60 ml·min-1·1.73m-2组和≤30 ml·min-1·1.73m-2组。术后72 h再次检测eGFR,按照术后肾功能变化将患者分为急性肾功能恢复(AKR)组、急性肾脏损伤(AKI)组和肾功能无变化组。其中AKR定义为TAVR术后72 h的eGFR值增加>基线值的25%,AKI定义为TAVR术后72 h的eGFR值降低>基线值的25%。比较各组的相关临床资料,并采用多因素logistic回归分析TAVR术后肾功能变化的影响因素。 结果: 本研究共纳入217例因主动脉瓣狭窄行TAVR治疗的患者,年龄(76.7±7.4)岁,其中女性86例,胸外科医师学会评分为(9.5±5.8)分。>90 ml·min-1·1.73m-2组(n=19)、>60~90 ml·min-1·1.73m-2组(n=116)、>30~60 ml·min-1·1.73m-2组(n=70)和≤30 ml·min-1·1.73m-2组(n=12)术后达AKR者所占比例分别为0、30.2%(35/116)、58.6%(41/70)和75.0%(9/12);共3例(1.4%)患者发生AKI,其中>30~60 ml·min-1·1.73m-2组2例,>60~90 ml·min-1·1.73m-2组1例。eGFR<60 ml·min-1·1.73m-2患者中AKI发生率为2.4%(2/82)。纳入的217例患者中,AKR组85例(39.2%)、AKI组3例(1.4%)、肾功能无变化组129例(59.4%)。3组的体重指数(BMI)、术前左心室舒张末期内径(LVEDD)和术前eGFR分布差异有统计学意义(P均<0.05)。多因素logistic回归分析显示,BMI(OR=5.54,95%CI 1.04~29.58,P=0.045)、术前LVEDD(OR=1.22,95%CI 1.09~1.38,P=0.001)及术前eGFR(OR=2.23,95%CI 2.04~2.55,P=0.004)是术后非AKR的危险因素。 结论: TAVR术后绝大多数患者表现为肾功能不变或者改善,TAVR术后肾功能的变化与BMI及术前LVDD、eGFR相关。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang LF, Zhang XC, Zhang Y, et al. [Impact of transcatheter aortic valve replacement on renal function in patients with severe aortic stenosis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021. PMID: 33429486. doi:10.3760/cma.j.cn112148-20200308-00173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。